Sexual and Reproductive Health and Rights at Work: The New Frontier for ESGs

Tuesday 16 January 2024 15:00-17:00 CET

Approximately 190 million women work in global supply chains concentrated in countries with high unmet needs for women’s health services. Businesses can be a key ally for delivering sexual and reproductive health information and services to millions of women across the world.

This session will focus on the implementation of women’s health and wellbeing in the workplace. Specifically, it will serve to launch the first of their kind, Sexual and Reproductive Health and Rights metrics for ESG reporting that will measure the impact of reproductive health programmes and services in a company’s day-to-day operations. It will convene business leaders, policymakers, foundations and philanthropic organizations, academia, civil society organizations among others with the goal to discuss the metrics and look at already existing relevant practices from the private sector, including concrete investments towards achieving inclusive workplaces.

Welcoming remarks by UNFPA Executive Director, Dr. Natalia Kanem

Moderated by Andrew Jack, Global Education Editor, Financial Times

With

Sanda Ojiambo, CEO, UN Global Compact
Kelly Clements, Deputy High Commissioner, UNHCR
Per Falk, President, Ferring Pharmaceuticals
Lorenzo Bertelli, Executive Director, Prada
Jan-Willem Scheijgrond, Vice President Government & Public Affairs at Royal Philips
Sahil Tesfu, Senior Vice President, Global Strategy & Business Development, Essity
Peter Paul van de Wijs, Chief External Affairs Officer, Global Reporting Initiative (GRI)
Dr. Roopa Dhatt, Executive Director and Co-Founder, Women in Global Health
Marijn Wiersma, Director of Community & Innovation, 2X Global
Shannon Cohn, Executive Producer, Below the Belt
Natasha Sunderji, Global Health Lead, Accenture
Khushbakht Shah Jillani, Founder of KSJ Legal and Global Shaper, Karachi Hub